The sensitivity to HCQ was higher in AML CD34-positive cells than in normal bone marrow CD34-positive cells, and when the cells were divided into those with high and low ROS levels, autophagy activity was higher in the ROS low group, and HCQ was more effective [70]. The gene discussed is CD34; the disease is acute myeloid leukemia.